KIDNEY CANCER
Clinical trials for KIDNEY CANCER explained in plain language.
Never miss a new study
Get alerted when new KIDNEY CANCER trials appear
Sign up with your email to follow new studies for KIDNEY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Double immune attack shows promise against kidney cancer
Disease control CompletedThis study tested a combination of two drugs that help the immune system fight cancer: high-dose interleukin-2 (IL-2) and pembrolizumab (Keytruda). It included 27 adults with metastatic kidney cancer that had spread beyond the kidney. The main goal was to see how many patients' t…
Matched conditions: KIDNEY CANCER
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 26, 2026 03:10 UTC
-
Can a drug keep kidney cancer away after surgery? large trial seeks answers
Disease control CompletedThis large phase III trial tested whether the drug everolimus, taken for about a year after kidney cancer surgery, could help prevent the cancer from coming back. Over 1,500 patients with intermediate- or high-risk kidney cancer participated. The study compared everolimus to a pl…
Matched conditions: KIDNEY CANCER
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 26, 2026 03:09 UTC
-
Sound waves zap kidney tumors in Needle-Free breakthrough
Disease control CompletedThis trial tested a new device that uses focused sound waves (histotripsy) to break apart solid kidney tumors without any cuts or needles. Twenty adults with small, non-spreading kidney tumors were treated to see if the procedure was safe and could fully cover the tumor. The goal…
Matched conditions: KIDNEY CANCER
Phase: NA • Sponsor: HistoSonics, Inc. • Aim: Disease control
Last updated May 26, 2026 03:05 UTC
-
New hope for kidney cancer patients with brain tumors?
Disease control CompletedThis study tested the drug sunitinib in 21 people with kidney cancer that had spread to the brain. The goal was to see if the drug could shrink brain tumors. Sunitinib works by blocking blood flow to cancer cells and stopping them from growing. The study was completed and looked …
Matched conditions: KIDNEY CANCER
Phase: PHASE2 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Breath sniffing device may pick cancer patients who respond to immunotherapy
Diagnosis CompletedThis study tested a breath analysis device (eNose) to see if it can predict which cancer patients will benefit from immunotherapy. Researchers collected breath samples from 190 adults with lung, melanoma, bladder, kidney, or head and neck cancers before treatment. The goal was to…
Matched conditions: KIDNEY CANCER
Sponsor: University Health Network, Toronto • Aim: Diagnosis
Last updated May 26, 2026 03:03 UTC
-
Kidney cancer study reveals Lifestyle's role in survival
Knowledge-focused CompletedThis study looked at how lifestyle factors like diet and exercise affect kidney cancer risk and recovery after kidney removal surgery. Researchers collected blood and tissue samples from 161 patients and asked them about their health habits. The goal was to understand how to pers…
Matched conditions: KIDNEY CANCER
Sponsor: University of Utah • Aim: Knowledge-focused
Last updated May 26, 2026 03:15 UTC